Avantor (NYSE:AVTR) Hits New 1-Year Low on Disappointing Earnings | MarketBeat

2022-07-31 15:43:41 By : Mr. Jack Wong

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Avantor, Inc. (NYSE:AVTR - Get Rating) hit a new 52-week low on Friday following a dissappointing earnings announcement. The stock traded as low as $27.51 and last traded at $28.34, with a volume of 115577 shares traded. The stock had previously closed at $32.33.

The company reported $0.37 EPS for the quarter, missing the consensus estimate of $0.38 by ($0.01). Avantor had a net margin of 7.72% and a return on equity of 32.17%. The business had revenue of $1.91 billion for the quarter, compared to analysts' expectations of $1.98 billion. During the same quarter in the prior year, the company posted $0.35 EPS. The business's revenue for the quarter was up 2.7% on a year-over-year basis. Wall Street Analyst Weigh In

AVTR has been the topic of several analyst reports. Raymond James cut their price target on Avantor from $43.00 to $40.00 and set an "outperform" rating on the stock in a research report on Monday, April 18th. The Goldman Sachs Group dropped their target price on Avantor from $42.00 to $37.00 and set a "buy" rating on the stock in a research report on Thursday, July 14th. Evercore ISI dropped their target price on Avantor from $44.00 to $42.00 and set an "outperform" rating on the stock in a research report on Monday, April 4th. Cowen decreased their price target on shares of Avantor from $50.00 to $44.00 in a research note on Tuesday, April 19th. Finally, Cowen decreased their price target on shares of Avantor from $50.00 to $44.00 in a research note on Tuesday, April 19th. One analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Avantor presently has an average rating of "Moderate Buy" and a consensus price target of $42.53.Insiders Place Their Bets

In related news, EVP Frederic Vanderhaegen sold 39,000 shares of Avantor stock in a transaction dated Monday, May 23rd. The shares were sold at an average price of $31.61, for a total value of $1,232,790.00. Following the sale, the executive vice president now directly owns 126,764 shares in the company, valued at approximately $4,007,010.04. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, EVP Gerard Brophy sold 19,603 shares of the business's stock in a transaction that occurred on Friday, May 20th. The shares were sold at an average price of $31.27, for a total transaction of $612,985.81. Following the transaction, the executive vice president now directly owns 96,935 shares of the company's stock, valued at $3,031,157.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Frederic Vanderhaegen sold 39,000 shares of Avantor stock in a transaction that occurred on Monday, May 23rd. The shares were sold at an average price of $31.61, for a total transaction of $1,232,790.00. Following the completion of the sale, the executive vice president now owns 126,764 shares of the company's stock, valued at $4,007,010.04. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders. Institutional Investors Weigh In On Avantor

Several institutional investors and hedge funds have recently bought and sold shares of the business. Asset Management One Co. Ltd. increased its stake in Avantor by 13.9% during the 2nd quarter. Asset Management One Co. Ltd. now owns 250,207 shares of the company's stock worth $7,781,000 after purchasing an additional 30,591 shares in the last quarter. Arizona State Retirement System lifted its holdings in shares of Avantor by 11.5% during the second quarter. Arizona State Retirement System now owns 170,238 shares of the company's stock worth $5,294,000 after buying an additional 17,557 shares in the last quarter. JB Capital LLC lifted its holdings in shares of Avantor by 4.9% during the second quarter. JB Capital LLC now owns 35,362 shares of the company's stock worth $1,100,000 after buying an additional 1,637 shares in the last quarter. North Star Asset Management Inc. increased its position in shares of Avantor by 4.2% in the second quarter. North Star Asset Management Inc. now owns 171,439 shares of the company's stock worth $5,331,000 after purchasing an additional 6,858 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. grew its position in Avantor by 9.1% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 81,244 shares of the company's stock valued at $2,526,000 after acquiring an additional 6,755 shares during the last quarter. Institutional investors own 93.24% of the company's stock. Avantor Stock Performance

The stock has a market cap of $17.50 billion, a P/E ratio of 31.35, a PEG ratio of 0.75 and a beta of 1.44. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.80 and a quick ratio of 1.18. The stock has a 50-day simple moving average of $31.04 and a 200-day simple moving average of $32.84. Avantor Company Profile (Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.See AlsoGet a free copy of the StockNews.com research report on Avantor (AVTR)Windfall Profits Have Exxon Mobil On Track For New HighsAdobe Stock, Why some investors are bullish, and others are notWas The Market Wrong On Etsy Again, As Shares Gain Post Earnings?Is Google The Buy Of The Summer?Should CVS Health Be in Your Portfolio?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Today Kate chats with Clark Kendall, CEO of Kendall Capital. Clark offers some practical steps to allocate your money, as well as invest for tax advantages.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.